COMMUNIQUÉS West-GlobeNewswire
-
Henrik Juuel Joins Bavarian Nordic as Chief Financial Officer
01/11/2018 - 08:00 -
Rule 2.9 Announcement
01/11/2018 - 08:00 -
Form 8 (DD) - Flemming Ornskov
01/11/2018 - 08:00 -
Novo Nordisk's operating profit decreased by 6% in Danish kroner and increased by 2% in local currencies in the first nine months of 2018
01/11/2018 - 07:31 -
Sanofi and Denali Therapeutics to develop treatments for neurological and inflammatory diseases
01/11/2018 - 07:01 -
Sanofi et Denali Therapeutics vont développer des médicaments pour le traitement de maladies neurologiques et inflammatoires
01/11/2018 - 07:01 -
Biocartis Group NV: Eight Idylla(TM) Performance Studies to be Presented at the Association for Molecular Pathology Conference in the US
01/11/2018 - 07:00 -
Denali Therapeutics Announces Broad Collaboration with Sanofi to Develop RIPK1 Inhibitors for the Treatment of Neurological and Inflammatory Diseases
01/11/2018 - 07:00 -
Oasmia completes a private placement of new convertible instruments in the amount SEK 80 million
01/11/2018 - 01:00 -
REVA Announces Commercial Launch of the Fantom Encore Bioresorbable Scaffold
01/11/2018 - 00:19 -
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/10/2018 - 23:56 -
Canada House Wellness Group Inc. Announces Results of Annual General Meeting and Issuance of Stock Options
31/10/2018 - 23:39 -
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31/10/2018 - 23:00 -
IHMA Announces a New Venture in India to Further Their Global Support of Anti-infective Drug Development for the Biopharmaceutical Industry
31/10/2018 - 22:22 -
UPDATE - Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018 - 22:16 -
LHC Group Announces Third Quarter 2018 Financial Results
31/10/2018 - 22:15 -
Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)
31/10/2018 - 22:02 -
Forty Seven Inc. Announces Publication in The New England Journal of Medicine of 5F9 Phase 1b Clinical Data in Non-Hodgkin’s Lymphoma (NHL)
31/10/2018 - 22:00 -
PRA Health Sciences, Inc. Reports Third Quarter 2018 Results and Updates 2018 Guidance
31/10/2018 - 21:39
Pages